This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
SAN DIEGO and LA JOLLA, Calif.,
Aug. 12, 2013 /PRNewswire/ --
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Orexigen Therapeutics, Inc. (NASDAQ: OREX) ("Orexigen") breached their fiduciary duties to shareholders. Orexigen focuses on the development of pharmaceutical product candidates for the treatment of obesity.